Axios Research
  • About Us
  • Products
  • Services
  • Support
  • Careers
  • Quote Cart

Products

Picture of Amlodipine Maleate
Amlodipine

Amlodipine Maleate

  • Catalogue #: AR-A01984
  • CAS #: 88150-47-4
  • Alternate CAS #: —
  • Molecular Formula: C₂₀H₂₅ClN₂O₅. C₄H₄O₄
  • Molecular weight: 408.89 116.07
H.S. code:29333999
Inventory Status:         Enquire
3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate maleate; 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester (z)-2-butenedioate;AMLODIPINE MALEATE;2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester (Z)-2-butenedioate

Amlodipine Maleate is a fully characterized chemical compound used as a reference standard of API Amlodipine Maleate. The standard offered is compliant with regulatory guidelines. Amlodipine Maleate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 88150-47-4

Related Products

Amlodipine

Amlodipine

M.F. C₂₀H₂₅ClN₂O₅

M.W. 408.88

CAT# AR-A03298

CAS# 88150-42-9

Amlodipine Besylate

Amlodipine Besylate

M.F. C₂₀H₂₅ClN₂O₅. C₆H₅SO₃H

M.W. 408.89; 158.18

CAT# AR-A01986

CAS# 111470-99-6

Amlodipine Benzoate

Amlodipine Benzoate

M.F. C₂₀H₂₅ClN₂O₅. C₇H₆O₂

M.W. 408.88 122.12

CAT# AR-A06388

CAS# 1239916-29-0

Axios Research

Quick Links

  • About Us
  • Services
  • Support
  • Career
  • Quote Cart

Contact

  • location20 De Boers Drive,
    Suite No. 540 Toronto,
    Ontario, Canada, M3J 0H1
  • phone416-623-0933
  • emailInfo@Axios-Research.com

Newsletter

© Copyright Axios Research 2024. All Rights Reserved.

Website Design by:Axios Research